Russia's Pharmstandard buys Biolek in Ukraine
This article was originally published in Scrip
Executive Summary
Russia's largest pharmaceutical manufacturer, Pharmstandard, has acquired its first asset in Ukraine - a 55% stake in the local company Biolek.